Nature Reviews Clinical Oncology Impact Factor, Indexing, Ranking 2024

Aims & ScopeNature Reviews' clinical content is written by internationally renowned clinical academics and researchers and targeted towards readers in the medical sciences, from postgraduate level upwards. While intended to be read by practicing doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any medical discipline.In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are proffered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals.Subjects Covered Chemotherapy Clinical pharmacology Diagnosis Epidemiology Experimental therapies Genetics Health services, economics and outcomes research Hematology Hormonal therapies Imaging Immunotherapy Medical oncology Palliative care Pathology Pediatric oncology Prevention Radiotherapy Screening Signal transduction Statistics Surgical oncology Targeted therapies

旨在与范围：Nature Reviews的临床内容由国际知名的医学学术研究人员撰写，旨在面向医学科学领域的读者，涵盖研究生水平及以上。尽管主要面向专科的执业医生、研究人员和学者，但我们致力于使所有文章对从事任何医学领域的读者均具有可及性。深度综述文章提供关于某一主题的权威、最新信息，并将其置于该领域的历史与发展背景中。在观点与新闻观点文章以及专题讨论中，我们提出具有针对性的讨论和观点，在研究亮点部分，我们筛选来自各专科和普通医学期刊的原始研究。涵盖的主题包括：化疗、临床药理学、诊断、流行病学、实验疗法、遗传学、医疗服务、经济与结果研究、血液学、激素疗法、成像、免疫疗法、医学肿瘤学、姑息治疗、病理学、儿科肿瘤学、预防、放射疗法、筛查、信号转导、统计学、外科肿瘤学、靶向疗法。